prlb20220802_8k.htm
false 0001443669 0001443669 2022-08-05 2022-08-05
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF
 
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): August 5, 2022
 
 
Proto Labs, Inc.
 
(Exact name of registrant as specified in its charter)
 
 
Minnesota
 
001-35435
 
41-1939628
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification Number)
 
 
5540 Pioneer Creek Drive
Maple Plain, Minnesota
 
55359
(Address of principal executive offices)
 
(Zip Code)
     
Registrant’s telephone number, including area code:
 
(763) 479-3680
 
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share
PRLB
New York Stock Exchange
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
 

 
 
Item 2.02.
Results of Operations and Financial Condition.
 
On August 5, 2022, Proto Labs, Inc. issued a press release announcing its second quarter 2022 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
 
Item 9.01.
Financial Statements and Exhibits.
 
(d) Exhibits
 
99.1
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
   
Proto Labs, Inc.
 
       
         
Date:
August 5, 2022
By:
/s/ Daniel Schumacher
 
     
Daniel Schumacher
 
     
Chief Financial Officer
 
 
 
 
 
ex_405548.htm

Exhibit 99.1

 

https://cdn.kscope.io/1ba6ea5e3811ec49fce45ea1dcaa1163-logo_only.jpg
https://cdn.kscope.io/1ba6ea5e3811ec49fce45ea1dcaa1163-logo02.jpg

 

Protolabs Reports Financial Results for the Second Quarter of 2022

 

Record Revenue of $126.9 million in the Second Quarter of 2022;

GAAP Earnings Per Share of $0.09, Non-GAAP Earnings Per Share of $0.46

 

MAPLE PLAIN, Minn. August 5, 2022 – Proto Labs, Inc. ("Protolabs" or "the company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the second quarter ended June 30, 2022.

 

Second Quarter 2022 Highlights include:

 

 

Revenue for the second quarter of 2022 was $126.9 million, representing a 3.1 percent increase compared to revenue of $123.0 million in the second quarter of 2021.

 

Hubs generated $11.3 million of revenue in the second quarter, representing year-over-year growth of 26.3 percent.

 

On a GAAP basis, costs related to the closure of Japan operations were $5.2 million in the quarter. These costs have been excluded from our Non-GAAP results. See “Non-GAAP Financial Measures” below.

 

Net income was $2.6 million, or $0.09 per diluted share.

 

Non-GAAP net income was $12.8 million, or $0.46 per diluted share.

 

“Protolabs performed well in the quarter amid continuing supply chain challenges in the broader manufacturing industry and macroeconomic growth concerns,” said Rob Bodor, President and Chief Executive Officer. “We continue to make progress on our 2022 strategic priorities and are focused to execute on the integration of Protolabs and Hubs, bringing together two leading digital manufacturing offers to create the most comprehensive digital manufacturing offer to serve our customers.”

 

Additional Second Quarter 2022 Highlights include:

 

 

Protolabs served 24,058 unique product developers during the second quarter of 2022.

 

Gross margin was 45.2 percent of revenue, compared to 44.9 percent of revenue in the first quarter of 2022.

 

Non-GAAP gross margin was 45.9 percent of revenue, compared to 45.7 percent of revenue in the first quarter of 2022.

 

EBITDA was $15.1 million, or 11.9 percent of revenue.

 

Adjusted EBITDA was $24.6 million, or 19.4 percent of revenue.

 

Cash and investments balance was $110.1 million as of June 30, 2022.

 

“We are pleased with the sequential improvements in our margins in the second quarter,” said Dan Schumacher, Chief Financial Officer. “We continue to focus on executing our strategy through disciplined investments and cost controls while delivering value to our customers and profitable growth to our shareholders.”

 

 

 

Non-GAAP Financial Measures

 

The company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates and revenue earned from our acquisition of Hubs (collectively, “non-GAAP revenue growth”). Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the company.

 

The company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, costs related to the Japan closure activities and transaction costs (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the company’s financial results. The company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, costs related to the Japan closure activities and transaction costs (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense, in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, costs related to the Japan closure activities and transaction costs (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has included non-GAAP gross margin excluding Japan, adjusted for stock-based compensation expense and amortization expense in this press release to provide investors with additional information regarding the company’s financial results. The company has included non-GAAP operating margin excluding Japan, adjusted for stock-based compensation expense, amortization expense, costs related to the Japan closure activities and transaction costs (collectively, “non-GAAP operating margin excluding Japan”), in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, costs related to Japan closure activities and transaction costs (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the company’s financial results.

 

The company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP gross margin, non-GAAP gross margin excluding Japan, non-GAAP operating margin, non-GAAP operating margin excluding Japan, non-GAAP revenue growth by region and by service, and Adjusted EBITDA and Adjusted EBITDA margin, to the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the company’s business. Accordingly, the company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

 

 

 

 

Conference Call

 

The company has scheduled a conference call to discuss its second quarter 2022 financial results and third quarter 2022 outlook today, August 5, 2022, at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/bfhv9mwu. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

 

About Protolabs

 

Protolabs is the world’s leading provider of digital manufacturing services. The e-commerce-based company offers injection molding, CNC machining, 3D printing, and sheet metal fabrication to product developers, engineers, and supply chain teams across the globe. Protolabs serves customers using in-house production capabilities that bring unprecedented speed in tandem with Hubs, a Protolabs Company, which serves customers through its network of premium manufacturing partners. Together, they help companies bring new ideas to market with the fastest and most comprehensive digital manufacturing service in the world. Visit protolabs.com for more information.

 

Forward-Looking Statements

 

Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

 

Source: Proto Labs, Inc.

 

Investor Relations Contact

Protolabs

Ryan Johnsrud, 612-225-4873

Manager – Investor Relations and FP&A

ryan.johnsrud@protolabs.com

 

Media Contact

Protolabs

Brent Renneke, 763-479-7704

PR & Media Strategist

brent.renneke@protolabs.com

 

 

 

Proto Labs, Inc.

Condensed Consolidated Balance Sheets

(In thousands)

 

 

   

June 30,

   

December 31,

 
   

2022

   

2021

 
   

(Unaudited)

         

Assets

               

Current assets

               

Cash and cash equivalents

  $ 54,666     $ 65,929  

Short-term marketable securities

    24,379       11,580  

Accounts receivable, net

    82,469       80,051  

Inventory

    15,051       13,161  

Income taxes receivable

    2,627       1,321  

Prepaid expenses and other current assets

    11,484       11,450  

Total current assets

    190,676       183,492  
                 

Property and equipment, net

    260,631       280,346  

Goodwill

    390,354       400,610  

Other intangible assets, net

    34,026       37,998  

Long-term marketable securities

    31,068       14,340  

Operating lease assets

    4,037       5,578  

Finance lease assets

    1,649       1,898  

Long-term assets held for sale

    1,985       -  

Other long-term assets

    4,223       4,320  

Total assets

  $ 918,649     $ 928,582  
                 

Liabilities and shareholders' equity

               

Current liabilities

               

Accounts payable

  $ 15,642     $ 25,364  

Accrued compensation

    16,687       13,704  

Accrued liabilities and other

    24,011       11,980  

Current operating lease liabilities

    2,140       3,298  

Current finance lease liabilities

    436       550  

Total current liabilities

    58,916       54,896  
                 

Long-term operating lease liabilities

    1,886       2,245  

Long-term finance lease liabilities

    1,188       1,351  

Long-term deferred tax liabilities

    30,177       35,892  

Other long-term liabilities

    5,784       5,705  
                 

Shareholders' equity

    820,698       828,493  

Total liabilities and shareholders' equity

  $ 918,649     $ 928,582  

 


 

 

 

Proto Labs, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share amounts)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 

Revenue

                               

Injection Molding

  $ 53,355     $ 58,168     $ 106,753     $ 114,527  

CNC Machining

    48,222       41,592       94,320       78,295  

3D Printing

    19,963       18,170       39,635       35,405  

Sheet Metal

    5,160       4,717       9,847       9,936  

Other

    202       401       515       1,011  

Total revenue

    126,902       123,048       251,070       239,174  
                                 

Cost of revenue

    69,480       66,423       137,844       127,219  

Gross profit

    57,422       56,625       113,226       111,955  
                                 

Operating expenses

                               

Marketing and sales

    21,055       21,044       41,641       40,524  

Research and development

    9,450       11,060       20,007       23,241  

General and administrative

    16,522       8,417       33,293       27,825  

Closure of Japan business

    5,194       -       5,194       -  

Total operating expenses

    52,221       40,521       100,135       91,590  

Income from operations

    5,201       16,104       13,091       20,365  

Other income (loss), net

    1       137       (299 )     (176 )

Income before income taxes

    5,202       16,241       12,792       20,189  

Provision for income taxes

    2,645       3,326       5,140       3,562  

Net income

  $ 2,557     $ 12,915     $ 7,652     $ 16,627  
                                 

Net income per share:

                               

Basic

  $ 0.09     $ 0.47     $ 0.28     $ 0.60  

Diluted

  $ 0.09     $ 0.47     $ 0.28     $ 0.60  
                                 

Shares used to compute net income per share:

                               

Basic

    27,530,739       27,735,732       27,515,583       27,600,684  

Diluted

    27,536,823       27,744,870       27,524,019       27,741,464  

 


 

 

 

Proto Labs, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

   

Six Months Ended

 
   

June 30,

 
   

2022

   

2021

 

Operating activities

               

Net income

  $ 7,652     $ 16,627  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Depreciation and amortization

    20,274       20,127  

Stock-based compensation expense

    8,428       10,561  

Deferred taxes

    (5,653 )     419  

Changes in fair value of contingent consideration

    -       (7,763 )

Impairments related to closure of Japan business

    1,792       -  

Other

    32       269  

Changes in operating assets and liabilities

    (1,485 )     (19,511 )

Net cash provided by operating activities

    31,040       20,729  
                 

Investing activities

               

Purchases of property, equipment and other capital assets

    (6,030 )     (23,929 )

Cash used for acquisitions, net of cash acquired

    -       (127,413 )

Purchases of marketable securities

    (38,882 )     (15,159 )

Proceeds from sales of marketable securities

    1,000       47,694  

Proceeds from call redemptions and maturities of marketable securities

    7,396       13,725  

Net cash used in investing activities

    (36,516 )     (105,082 )
                 

Financing activities

               

Proceeds from exercises of stock options and other

    2,311       3,838  

Purchases of shares withheld for tax obligations

    (1,615 )     (4,209 )

Repurchases of common stock

    (5,239 )     (1,210 )

Principal repayments of finance lease obligations

    (278 )     (275 )

Net cash used in financing activities

    (4,821 )     (1,856 )

Effect of exchange rate changes on cash and cash equivalents

    (966 )     515  

Net decrease in cash and cash equivalents

    (11,263 )     (85,694 )

Cash and cash equivalents, beginning of period

    65,929       127,603  

Cash and cash equivalents, end of period

  $ 54,666     $ 41,909  

 


 

 

 

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Net Income per Share

(In thousands, except share and per share amounts)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 

Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, costs related to Japan closure activities and transaction costs

                               

GAAP net income

  $ 2,557     $ 12,915     $ 7,652     $ 16,627  

Add back:

                               

Stock-based compensation expense

    4,031       4,941       8,428       10,561  

Amortization expense

    1,527       1,490       3,072       3,033  

Unrealized (gain) loss on foreign currency

    271       (402 )     360       220  

Costs related to Japan closure activities

    5,194       -       5,194       -  

Transaction costs 1

    -       (7,655 )     -       (5,140 )

Total adjustments 2

    11,023       (1,626 )     17,054       8,674  

Income tax benefits on adjustments 3

    (776 )     (575 )     (1,458 )     (3,576 )

Non-GAAP net income

  $ 12,804     $ 10,714     $ 23,248     $ 21,725  
                                 
                                 

Non-GAAP net income per share:

                               

Basic

  $ 0.47     $ 0.39     $ 0.84     $ 0.79  

Diluted

  $ 0.46     $ 0.39     $ 0.84     $ 0.78  
                                 

Shares used to compute non-GAAP net income per share:

                               

Basic

    27,530,739       27,735,732       27,515,583       27,600,684  

Diluted

    27,536,823       27,744,870       27,524,019       27,741,464  

 


 

1 Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

2 Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, costs related to Japan closure activities and transaction costs were included in the following GAAP consolidated statement of operations categories:

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 
                                 

Cost of revenue

  $ 870     $ 1,011     $ 1,799     $ 1,988  
                                 

Marketing and sales

    813       929       1,550       1,782  

Research and development

    471       744       1,100       1,368  

General and administrative

    3,404       (3,908 )     7,051       3,316  

Closure of Japan business

    5,194       -       5,194       -  

Total operating expenses

    9,882       (2,235 )     14,895       6,466  
                                 

Other (income) expense, net

    271       (402 )     360       220  

Total adjustments

  $ 11,023     $ (1,626 )   $ 17,054     $ 8,674  

 

3 For the three- and six-month periods ended June 30, 2022 and 2021, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.

 


 

 

 

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Gross Margin

(In thousands)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

   

Three Months Ended

 
   

June 30,

   

June 30,

   

March 31,

 
   

2022

   

2021

   

2022

   

2021

   

2022

   

2021

 

Revenue

  $ 126,902     $ 123,048     $ 251,070     $ 239,174     $ 124,168     $ 116,126  

Gross Profit

    57,422       56,625       113,226       111,955       55,804       55,330  

GAAP gross margin

    45.2 %     46.0 %     45.1 %     46.8 %     44.9 %     47.6 %

Add back:

                                               

Stock-based compensation expense

    528       668       1,115       1,303       587       635  

Amortization expense

    342       343       684       685       342       342  

Total adjustments

    870       1,011       1,799       1,988       929       977  

Non-GAAP gross profit

  $ 58,292     $ 57,636     $ 115,025     $ 113,943     $ 56,733     $ 56,307  

Non-GAAP gross margin

    45.9 %     46.8 %     45.8 %     47.6 %     45.7 %     48.5 %

 


 

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Gross Margin Excluding Japan

(In thousands)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 

Revenue

  $ 126,902     $ 123,048     $ 251,070     $ 239,174  

Revenue excluding Japan

  $ 124,046     $ 119,999     $ 244,128     $ 232,501  

Gross Profit

    57,422       56,625       113,226       111,955  

GAAP gross margin

    45.2 %     46.0 %     45.1 %     46.8 %

Less: Japan gross profit

    1,063       1,125       3,102       2,694  

Gross Profit excluding Japan

    56,359       55,500       110,124       109,261  

GAAP gross margin excluding Japan

    45.4 %     46.3 %     45.1 %     47.0 %

Add back:

                               

Stock-based compensation expense

    528       668       1,115       1,303  

Amortization expense

    342       343       684       685  

Less:

                               

Japan stock-based compensation expense

    22       22       47       45  

Japan amortization expense

    -       -       -       -  

Total adjustments

    848       989       1,752       1,943  

Non-GAAP gross profit excluding Japan

  $ 57,207     $ 56,489     $ 111,876     $ 111,204  

Non-GAAP gross margin excluding Japan

    46.1 %     47.1 %     45.8 %     47.8 %

 


 

 

 

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Operating Margin

(In thousands)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 

Revenue

  $ 126,902     $ 123,048     $ 251,070     $ 239,174  

Income from operations

    5,201       16,104       13,091       20,365  

GAAP operating margin

    4.1 %     13.1 %     5.2 %     8.5 %

Add back:

                               

Stock-based compensation expense

    4,031       4,941       8,428       10,561  

Amortization expense

    1,527       1,490       3,072       3,033  

Transaction costs 1

    -       (7,655 )     -       (5,140 )

Costs related to Japan closure activities

    5,194       -       5,194       -  

Total adjustments

    10,752       (1,224 )     16,694       8,454  

Non-GAAP income from operations

  $ 15,953     $ 14,880     $ 29,785     $ 28,819  

Non-GAAP operating margin

    12.6 %     12.1 %     11.9 %     12.0 %

 


 

1 Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

 


 

Proto Labs, Inc.

Reconciliation of GAAP to Non-GAAP Operating Margin Excluding Japan

(In thousands)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 

Revenue

  $ 126,902     $ 123,048     $ 251,070     $ 239,174  

Revenue excluding Japan

  $ 124,046     $ 119,999     $ 244,128     $ 232,501  

Income from operations

    5,201       16,104       13,091       20,365  

GAAP operating margin

    4.1 %     13.1 %     5.2 %     8.5 %

Less: Japan income from operations

    (542 )     (696 )     4       (654 )

Income from operations excluding Japan

    5,743       16,800       13,087       21,019  

GAAP operating margin excluding Japan

    4.6 %     14.0 %     5.4 %     9.0 %

Add back:

                               

Stock-based compensation expense

    4,031       4,941       8,428       10,561  

Amortization expense

    1,527       1,490       3,072       3,033  

Transaction costs 1

    -       (7,655 )     -       (5,140 )

Costs related to Japan closure activities

    5,194       -       5,194       -  

Less:

                               

Japan stock-based compensation expense

    147       160       297       303  

Japan amortization expense

    -       -       -       -  

Total adjustments

    10,605       (1,384 )     16,397       8,151  

Non-GAAP income from operations excluding Japan

  $ 16,348     $ 15,416     $ 29,484     $ 29,170  

Non-GAAP operating margin excluding Japan

    13.2 %     12.8 %     12.1 %     12.5 %

 


 

1 Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

 


 

 

 

Proto Labs, Inc.

Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA

(In thousands)

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 

Revenue

  $ 126,902     $ 123,048     $ 251,070     $ 239,174  

GAAP net income

    2,557       12,915       7,652       16,627  

GAAP net income margin

    2.0 %     10.5 %     3.0 %     7.0 %

Add back:

                               

Amortization expense

  $ 1,527     $ 1,490     $ 3,072     $ 3,033  

Depreciation expense

    8,515       8,578       17,202       17,094  

Interest income, net

    (149 )     (65 )     (194 )     (152 )

Tax expense

    2,645       3,326       5,140       3,562  

EBITDA

    15,095       26,244       32,872       40,164  

EBITDA Margin

    11.9 %     21.3 %     13.1 %     16.8 %

Add back:

                               

Stock-based compensation expense

    4,031       4,941       8,428       10,561  

Unrealized (gain) loss on foreign currency

    271       (402 )     360       220  

Costs related to Japan closure activities

    5,194       -       5,194       -  

Transaction costs 1

    -       (7,655 )     -       (5,140 )

Total adjustments

    9,496       (3,116 )     13,982       5,641  

Adjusted EBITDA

  $ 24,591     $ 23,128     $ 46,854     $ 45,805  

Adjusted EBITDA Margin

    19.4 %     18.8 %     18.7 %     19.2 %

 


 

1 Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. and the impact of changes in the fair value of acquisition-related contingent consideration obligations.

 


 

 

 

Proto Labs, Inc.

Comparison of GAAP to Non-GAAP Revenue Growth by Region

(In thousands)

(Unaudited)

 

   

Three Months Ended
June 30, 2022

   

Three Months Ended
June 30, 2021

   

%

         
   

GAAP

   

Foreign

Currency1

   

Hubs

Acquisition

   

Non-GAAP

   

GAAP

   

Change3

   

% Change

Organic4

 

Revenues

                                                       

United States

  $ 100,655     $ -     $ -     $ 100,655     $ 95,344       5.6

%

    5.6

%

Europe

    23,391       2,225       -       25,616       24,655       (5.1 )     3.9  

Japan

    2,856       524       -       3,380       3,049       (6.3 )     10.9  

Total Revenue

  $ 126,902     $ 2,749     $ -     $ 129,651     $ 123,048       3.1

%

    5.4

%

 


 

   

Six Months Ended
June 30, 2022

   

Six Months Ended
June 30, 2021

   

%

         
   

GAAP

   

Foreign

Currency1

   

Hubs

Acquisition2

   

Non-GAAP

   

GAAP

   

Change3

   

% Change

Organic4

 

Revenues

                                                       

United States

  $ 196,151     $ -     $ (1,049 )   $ 195,102     $ 186,397       5.2

%

    4.7

%

Europe

    47,977       3,376       (1,279 )     50,074       46,104       4.1       8.6  

Japan

    6,942       916       -       7,858       6,673       4.0       17.8  

Total Revenue

  $ 251,070     $ 4,292     $ (2,328 )   $ 253,034     $ 239,174       5.0

%

    5.8

%

 

1 Revenue for the three- and six-month periods ended June 30, 2022 has been recalculated using 2021 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.

 

2 Revenue for the six-month period ended June 30, 2022 has been recalculated to exclude revenue earned from the Company's acquisition of Hubs, Inc. for the period from January 1, 2022 to January 21, 2022 to provide information useful in evaluating the underlying business trends excluding the impact of acquisitions. The Hubs, Inc. acquisition occurred on January 22, 2021 and was included in 2021 revenue after that date.

 

3 This column presents the percentage change from GAAP revenue for the three- and six-month periods ended June 30, 2021 to GAAP revenue for the three- and six-month periods ended June 30, 2022.

 

4 This column presents the percentage change from GAAP revenue for the three- and six-month periods ended June 30, 2021 to non-GAAP revenue for the three- and six-month periods ended June 30, 2022 (as recalculated using the foreign currency exchange rates in effect during the three-month period ended June 30, 2021, excluding the impact of Hubs, Inc. acquisition) in order to provide a constant-currency comparison.

 

 

 

 

Proto Labs, Inc.

Comparison of GAAP to Non-GAAP Revenue Growth by Service Line

(In thousands)

(Unaudited)

 

   

Three Months Ended
June 30, 2022

   

Three Months Ended
June 30, 2021

   

%

         
   

GAAP

   

Foreign Currency1

   

Hubs Acquisition

   

Non-GAAP

   

GAAP

   

Change3

   

% Change Organic4

 

Revenues

                                                       

Injection Molding

  $ 53,355     $ 1,541     $ -     $ 54,896     $ 58,168       (8.3

)%

    (5.6

)%

CNC Machining

    48,222       717       -       48,939       41,592       15.9       17.7  

3D Printing

    19,963       490       -       20,453       18,170       9.9       12.6  

Sheet Metal

    5,160       -       -       5,160       4,717       9.4       9.4  

Other

    202       1       -       203       401       (49.6 )     (49.4 )

Total Revenue

  $ 126,902     $ 2,749     $ -     $ 129,651     $ 123,048       3.1

%

    5.4

%

 


 

   

Six Months Ended
June 30, 2022

   

Six Months Ended
June 30, 2021

   

%

         
   

GAAP

   

Foreign Currency1

   

Hubs Acquisition2

   

Non-GAAP

   

GAAP

   

Change3

   

% Change Organic4

 

Revenues

                                                       

Injection Molding

  $ 106,753     $ 2,425     $ (189 )   $ 108,989     $ 114,527       (6.8

)%

    (4.8

)%

CNC Machining

    94,320       1,113       (1,637 )     93,796       78,295       20.5       19.8  

3D Printing

    39,635       750       (408 )     39,977       35,405       11.9       12.9  

Sheet Metal

    9,847       -       (84 )     9,763       9,936       (0.9 )     (1.7 )

Other

    515       4       (10 )     509       1,011       (49.1 )     (49.6 )

Total Revenue

  $ 251,070     $ 4,292     $ (2,328 )   $ 253,034     $ 239,174       5.0

%

    5.8

%

 

1 Revenue for the three- and six-month periods ended June 30, 2022 has been recalculated using 2021 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.

 

2 Revenue for the six-month period ended June 30, 2022 has been recalculated to exclude revenue earned from the Company's acquisition of Hubs, Inc. for the period from January 1, 2022 to January 21, 2022 to provide information useful in evaluating the underlying business trends excluding the impact of acquisitions. The Hubs, Inc. acquisition occurred on January 22, 2021 and was included in 2021 revenue after that date.

 

3 This column presents the percentage change from GAAP revenue for the three- and six-month periods ended June 30, 2021 to GAAP revenue for the three- and six-month periods ended June 30, 2022.

 

4 This column presents the percentage change from GAAP revenue for the three- and six-month periods ended June 30, 2021 to non-GAAP revenue for the three- and six-month periods ended June 30, 2022 (as recalculated using the foreign currency exchange rates in effect during the three-month period ended June 30, 2021, excluding the impact of Hubs, Inc. acquisition) in order to provide a constant-currency comparison.

 

 

 

 

Proto Labs, Inc.

Product Developer Information

(Unaudited)

 

   

Three Months Ended

   

Six Months Ended

 
   

June 30,

   

June 30,

 
   

2022

   

2021

   

2022

   

2021

 

Unique product developers and engineers served

    24,058       23,253       36,878       35,065